North America Inhalable Drugs Market Size, Share, Future Prospects and Forecast 2020-2026

By | November 5, 2020

The North American inhalable drug market is anticipated to grow at a CAGR of 2.8% during the forecast period (2020-2026). The key factor that drives the growth of the North American inhalable drug market includes the increased prevalence of respiratory and non-respiratory diseases across the region along with the presence of several local and multi-national players such as Johnsons and Johnsons, Novartis, Pfizer, and others.

Please read the originial post here: